Analysis of vitamin D levels in patients with and without statin-associated myalgia - A systematic review and meta-analysis of 7 studies with 2420 patients

International Journal of Cardiology

Volumn 178, Issue , 2015, Pages 111-116

  Michalska Kasiczak, Marta ^a   Sahebkar, Amirhossein ^b,c   Mikhailidis, Dimitri P ^d   Rysz, Jacek ^a   Muntner, Paul ^e   Toth, Peter P ^f,g   Jones, Steven R ^g   Rizzo, Manfredi ^h   Kees Hovingh, G ⁱ   Farnier, Michel ^j   Moriarty, Patrick M ^k   Bittner, Vera A ^l   Lip, Gregory Y H ^m   Banach, Maciej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f CGH Medical Center   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNIVERSITY OF PALERMO   (Italy)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

^j Academic Medical Center ^*  (France)

^k UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^l University of Alabama at Birmingham   (United States)

^m UNIVERSITY OF BIRMINGHAM   (United Kingdom)

more..

Author keywords

Myalgia; Statin intolerance; Statin associated myalgia; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; BIOLOGICAL MARKERS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; VITAMIN D;

AGE DISTRIBUTION; BODY MASS; CARDIOVASCULAR MORTALITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; HUMAN; META ANALYSIS (TOPIC); MORBIDITY; MYALGIA; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; SEX DIFFERENCE; STATIN ASSOCIATED MYALGIA; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; CHEMICALLY INDUCED; COMPARATIVE STUDY; HUMANS; META ANALYSIS; METHODS; OBSERVATIONAL STUDY AS TOPIC;

BIOLOGICAL MARKERS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYALGIA; OBSERVATIONAL STUDY AS TOPIC; VITAMIN D;

EID: 84916238750     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.10.118     Document Type: Article

References (45)

1. F. Taylor, M.D. Huffman, A.F. Macedo, T.H. Moore, M. Burke, and G. Davey Smith Statins for the primary prevention of cardiovascular disease Cochrane Database Syst. Rev. 1 2013 (CD004816)
2. Z. Reiner Statins in the primary prevention of cardiovascular disease Nat. Rev. Cardiol. 10 8 2013 453 464
3. J. Kowalski, M. Barylski, M. Banach, J. Grycewicz, R. Irzmański, and L. Pawlicki Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention J. Cardiovasc. Pharmacol. 48 4 2006 143 147
4. V.G. Athyros, N. Katsiki, K. Tziomalos, T.D. Gossios, E. Theocharidou, E. Gkaliagkousi GREACE Study Collaborative Group Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study Arch. Med. Sci. 9 3 2013 418 426
5. M. Barylski, S. Nikfar, D.P. Mikhailidis, P.P. Toth, P. Salari, and K.K. Ray Lipid and Blood Pressure Meta-Analysis Collaboration Group. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy - a meta-analysis of 11 randomized controlled trials involving 21,295 participants Pharmacol. Res. 72 2013 35 44
6. H.M. Lai, W.S. Aronow, A.D. Mercando, P. Kalen, H.V. Desai, and K. Gandhi The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice Arch. Med. Sci. 8 1 2012 53 56
7. X. Sheng, M.J. Murphy, T.M. MacDonald, and L. Wei Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study Eur. J. Clin. Pharmacol. 68 8 2012 1201 1208
8. C. Aboa-Eboule', C. Binquet, A. Jacquin, M. Hervieu, and C. Bonithon-Kopp Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study J. Neurol. 260 1 2013 30 37
9. I. Szadkowska, A. Stanczyk, W.S. Aronow, J. Kowalski, L. Pawlicki, and A. Ahmed Statin therapy in the elderly: a review Arch. Gerontol. Geriatr. 50 1 2010 114 118
10. M. Rizzo, D. Nikolic, M. Banach, and G. Montalto Statin treatment in the elderly: how much do we know? Arch. Med. Sci. 9 4 2013 585 588
11. N.J. Stone, J. Robinson, and A.H. Lichtenstein 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 63 2014 2889 2932
12. T.R. Joy, and R.A. Hegele Narrative review: statin-related myopathy Ann. Intern. Med. 150 12 2009 858 868
13. L.S. Rallidis, K. Fountoulaki, and M. Anastasiou-Nana Managing the underestimated risk of statin-associated myopathy Int. J. Cardiol. 159 3 2012 169 176
14. E. Bruckert, G. Hayem, S. Dejager, C. Yau, and B. Bégaud Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients - the PRIMO study Cardiovasc. Drugs Ther. 19 6 2005 403 414
15. S. Sathasivam Statin induced myotoxicity Eur. J. Intern. Med. 23 2012 317 324
16. M. Rizzo, M. Banach, G. Montalto, and D.P. Mikhailidis Lipid-lowering therapies and achievement of LDL-cholesterol targets Arch. Med. Sci. 8 4 2012 598 600
17. V. Fung, F. Sinclair, H. Wang, D. Dailey, J. Hsu, and R. Shaber Patients' perspectives on nonadherence to statin therapy: a focus-group study Perm. J. 14 1 2010 4 10
18. P.D. Thompson, P. Clarkson, and R.H. Karas Statin-associated myopathy JAMA 289 13 2003 1681 1690
19. A. Gupta, and P.D. Thompson The relationship of vitamin D deficiency to statin myopathy Atherosclerosis 215 1 2011 23 29
20. M. Harari, E. Dramsdahl, and S. Shany Increased vitamin D serum levels correlate to clinical improvement of rheumatic disease after Dead Sea climatotherapy IMAJ 13 4 2011 212 215
21. W. Ahmed, N. Khan, and C.J. Glueck Low serum 25 (OH) vitamin D levels (< 32 ng/ml) are associated with reversible myositis-myalgia in statin-treated patients Transl. Res. 153 1 2009 11 16
22. J.J. DiNicolantonio CoQ10 and L-carnitine for statin myalgia? Expert. Rev. Cardiovasc. Ther. 10 10 2012 1329 1333
23. M. Banach, C. Serban, and A. Sahebkar Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials Mayo Clin. Proc. 2014 10.1016/j.mayocp.2014.08.021
24. H. Paiva, K.M. Thelen, R. Van Coster, J. Smet, and B. De Paepe High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial Clin. Pharmacol. Ther. 78 1 2005 60
25. G. Ruano, A. Windemuth, A.H. Wu, J.P. Kane, and M.J. Malloy Mechanisms of statin-induced myalgia assessed by physiogenomic associations Atherosclerosis 218 2 2011 451 456
26. R.P. Gupta, Y.A. He, K.S. Patrick, J.R. Halpert, and N.H. Bell CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis J. Clin. Endocrinol. Metab. 90 2 2005 1210 1219
27. D. Moher, A. Liberati, and J. Tetzlaff Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int. J. Surg. 8 5 2010 336 341
28. S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med. Res. Methodol. 20 2005 13
29. http://getdata-graph-digitizer.com/.
30. A. Sahebkar Does PPARγ2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis DNA Cell Biol. 32 4 2013 188 198
31. S. Duval, and R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2 2000 455 463
32. M. Borenstein, L. Hedges, J. Higgins, and H. Rothstein Comprehensive Meta-analysis: A Computer Program for Meta-analysis [Computer Software; Version 2] 2005 Biostat Inc. Englewood, NJ
33. B. Duell, and W.E. Connor Vitamin D deficiency is associated with myalgias in hyperlipidemic subjects taking statins Circulation 118 2008 S470
34. R. Linde, L. Peng, M. Desai, and D. Feldman The role of vitamin D and SLCO1B1∗5 gene polymorphism in statin-associated myalgias Dermatoendocrinol 2 2 2010 77 84
35. J.M. Backes, B.J. Barnes, J.F. Ruisinger, and P.M. Moriarty A comparison of 25-hydroxyvitamin D serum levels among those with or without statin-associated myalgias Atherosclerosis 218 1 2011 247 249
36. I.J1. Riphagen, E. van der Veer, F.A. Muskiet, and M.J. DeJongste Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D Curr. Med. Res. Opin. 28 7 2012 1247 1252
37. A. Eisen, E. Lev, Z. Iakobishvilli, A. Porter, D. Brosh, and D. Hasdai Low plasma vitamin D levels and muscle-related adverse effects in statin users Isr. Med. Assoc. J. 16 1 2014 42 45
38. G. Palamaner Subash Shantha, J. Ramos, L. Thomas-Hemak, and S.B. Pancholy Association of vitamin D and incident statin induced myalgia - a retrospective cohort study PLoS One 9 2 2014 e88877
39. S. Dragan, M.C. Serban, and M. Banach Proprotein convertase subtilisin/kexin 9 inhibitors: an emerging lipid-lowering therapy? J. Cardiovasc. Pharmacol. Ther. 2014 10.1177/1074248414539562
40. M. Banach, C. Serban, W.S. Aronow, J. Rysz, S. Dragan, and E.V. Lerma Lipid, blood pressure and kidney update 2013 Int. Urol. Nephrol. 46 5 2014 947 961
41. J.B. Schwartz Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence Clin. Pharmacol. Ther. 85 2 2009 198 203
42. C.J. Glueck, C. Abuchaibe, and P. Wang Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle Med. Hypotheses 77 4 2011 658 661
43. P. Lee, J.R. Greenfield, and L.V. Campbell Vitamin D insufficiency - a novel mechanism of statin-induced myalgia? Clin. Endocrinol. (Oxf.) 71 1 2009 154 155
44. D. Kurnik, I. Hochman, and J. Vesterman-Landes Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins Clin. Endocrinol. (Oxf.) 77 1 2012 36 41
45. K. Tziomalos, V.G. Athyros, and D.P. Mikhailidis Statin discontinuation: an underestimated risk? Curr. Med. Res. Opin. 24 11 2008 3059 3062